JPMorgan Chase & Co. Reiterates “Neutral” Rating for Amphastar Pharmaceuticals (NASDAQ:AMPH)
Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report)‘s stock had its “neutral” rating reiterated by JPMorgan Chase & Co. in a research note issued on Monday, Marketbeat.com reports. They currently have a $30.00 price objective on the stock, down from their previous price objective of $45.00. JPMorgan Chase & Co.‘s price objective would suggest a potential […]
Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report)‘s stock had its “neutral” rating reiterated by JPMorgan Chase & Co. in a research note issued on Monday, Marketbeat.com reports. They currently have a $30.00 price objective on the stock, down from their previous price objective of $45.00. JPMorgan Chase & Co.‘s price objective would suggest a potential […]
